Ramsay Health Care Deutsche Bank Australia Corporate Day London 12 March 2013 Christopher Rex, Managing Director Bruce Soden, Chief Financial Officer
AGENDA 1. Ramsay Health Care Overview 2. Growth Story & Formula for Success 3. Half-year Group Operational & Financial Highlights 4. Half-year Operational & Financial Highlights - by Country 5. Outlook 2
RAMSAY HEALTH CARE OVERVIEW One of the largest & most successful private hospital operators in the world: Operating 116 hospitals & facilities across 4 countries 10,000 beds 30,000 staff Treating over 1 million patients per annum Extensive education & training, including Ramsay Training Institute, Graduate Employment & Future Leaders Programmes Revenue running at over A$4 billion Market capitalisation over A$6 billion Enterprise value over A$7 billion 3
4
OUR FORMULA FOR SUCCESS Management and culture Long term, stable management team, special culture ( The Ramsay Way ) Ramsay can export proven management model and blend it with local expertise Modus operandi and strong growth strategy Ramsay s growth strategy has remained clear and consistent Focused solely on operating & managing private hospitals Manage & invest for the long term Focus is on the provision of quality care profits will follow Financially disciplined Growth only pursued if financial and strategic criteria and investment hurdles (15% ROIC) are satisfied 5
STRONG GROWTH STRATEGY Sustainable growth enhanced by focusing on hospitals and taking a prudent approach to acquisitions Organic Brownfield Capacity Expansion Public/Private Collaborations + + + Acquisitions Creation of Shareholder Value Underpinned by demographics, quality portfolio of hospitals, ongoing business improvement Unmet demand driving Ramsay s ongoing investment in capacity expansion Potential for more partnerships to develop/manage/ provide hospital services in changing political and demographic landscape Exploring further acquisitions in existing and other markets Ramsay has proven it can export its management model Must add longterm value to shareholders 6
CONSISTENTLY DELIVERING STRONG TOTAL SHAREHOLDER RETURNS (TSR) Compound Annual Rate of Growth over 15 years Ramsay Health Care TSR 24.3% 22-Feb-13 2,731% Vs S&P/ASX 100 Acc Index 8.3% 22-Feb-13 243% (1) SOURCE: Deutsche Bank (1) Ramsay Health Care Listed on ASX 23 September 1997 7
RAMSAY HEALTH CARE TSR ALPHA TM PERFORMANCE Ramsay ranked (1) third in a survey of Australian ASX100 companies, in terms of TSR Alpha TM performance over the five-year period to 31 December 2012 The TSR Alpha TM scorecard is a stand alone metric that takes into account : Total shareholder return The market value of the investment The consistency of a company s performance in creating shareholder wealth The scorecard acknowledges the quality and capability of the company s management team in continually delivering positive TSR Alpha TM (1) SOURCE: Alpha Performance & Reward, February 2013 8
9
FINANCIAL HIGHLIGHTS - 1 ST HALF FY 2013 Group Revenue $2.1 billion 5.2% Group EBIT $248.4 million 8.8% Core NPAT $148.2 million 12.3% Core EPS 69.1 cents/share 13.7% Interim Dividend (fully franked) 29.0 cents/share 13.7% Upgraded guidance for Core NPAT and Core EPS growth to 13% - 15% for FY2013( previously 10% - 12%) Notes: Results for the six months ended 31 December 2012 All amounts are in Australian dollars unless otherwise stated 10
OPERATIONAL HIGHLIGHTS Results reflect solid performance across worldwide portfolio Completed brownfield capacity expansion projects meeting growing demand and adding to EBIT and EPS In Australia, private health insurance membership remains strong (46.9% with hospital treatment insurance) despite recent changes to private health care policy Selected in the 2013 Global 100 Most Sustainable Companies in the World for the second year in a row 11
BROWNFIELD (CAPACITY EXPANSION) DEVELOPMENTS Proven track record of undertaking successful brownfield expansion Extensive programme of hospital redevelopments & expansions currently underway Approximately $95 million spent on brownfield projects in the half year. A further $91 million for brownfield capacity expansion approved during the six month period Projected ongoing pipeline of brownfield investments of at least $100 million pa to increase capacity, required to provide services to the ageing and growing population Completed brownfield developments adding to earnings at the EBIT & EPS level & on track to achieve 15% ROI 12
LEVERAGE & CASH MANAGEMENT Leverage Cash Flow 6X Affinity Acquisition $1.4b $m 5X 4X 5.1 Capio UK Acquisition 193m 3.7 3.3 Ramsay Santé Acquisition 87m 350 300 250 3X 2X 2.7 2.7 2.4 1.9 1.5 1.5 200 150 Dec'11 Dec'12 1X FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12 Dec'12 Leverage = Net Debt EBITDA Gross Operating Cash Flow EBITDA Continuing strong operating cash flow has allowed Ramsay to invest significantly in brownfields whilst maintaining a low leverage ratio Effective working capital management delivered a high cash conversion rate for the Group of more than 100% of operating profit (EBITDA) to gross operating cash flow 13
14
GEOGRAPHICAL SEGMENTS Operating Revenue EBITDAR 13% 5% 18% 4% 2% 2% 80% 76% Australia Indonesia United Kindom France Australia Indonesia United Kingdom France Strong Australian business is the largest contributor to earnings and cash flow 15
OPERATIONAL/FINANCIAL HIGHLIGHTS AUSTRALIA Revenue up 7% to $1.66 billion EBIT up 10% to $219 million Australian hospital EBITDA margin up 50 bpts to 18.6% Private health insurance (PHI) membership remains strong despite challenges presented by changes to PHI policy recently Demand for health care continues to increase with ageing and expanding population which drives our investment in brownfield capacity expansion Strong indications that State Governments will procure more input from private sector in planning, building and operating public hospitals 16
OPERATIONAL/FINANCIAL HIGHLIGHTS INDONESIA Strong operating result for the half year Revenue up 11% to IDR 316 billion EBIT up 46% to IDR 33 billion EBITDA margin up 180 bpts to 16.3% Continued opportunity to grow Emerging market with burgeoning middle class and ageing population 17
OPERATIONAL/FINANCIAL HIGHLIGHTS EUROPE Ramsay UK Revenue up 1.5% to 179 million EBITDAR up 1.5% to 45 million EBITDAR margin remains strong at 25% Private Medical Insured admissions remain subdued but continued growth from NHS admissions with 9% growth over the previous corresponding period NHS now comprises almost 70% of total admissions Competition Commission process is ongoing however, health care reform expected to provide continuing opportunities for the private sector Ramsay Santé France Ramsay Santé performed to expectations Revenue up 1.5% to 80 million EBITDAR up 3.4% to 13 million EBITDAR margin up 30 bpts to 15.8% 18
19
GLOBAL MARKET TRENDS IN HEALTHCARE Growing & ageing population will continue to drive demand for healthcare Governments increasingly concerned about the rising costs of healthcare Patients looking for & willing to pay for higher quality healthcare Increasing GDP & affordability driving growth for private operators Significant growth in healthcare spend expected in emerging markets 20
OUTLOOK Positive market dynamics indicate strong upside for Ramsay Growing and ageing population will continue to drive our investment in capacity expansion Remain positive about opportunities overseas including emerging markets and the opportunity to apply our proven health care management expertise in these markets Continue to investigate acquisition opportunities in existing markets in both the private and public sectors Given strong industry fundamentals and continuing implementation of our successful growth strategy and barring unforeseen circumstances, Ramsay upgrades FY 2013 guidance for Core NPAT and Core EPS growth for the Group to 13% - 15% (previously 10% - 12%) 21